Evidence map›Paper›PMID 41410180›Full record

ArticleEuropean journal of immunology2025

Functional Antigen-Specific CD8 T

Yanran Zhao, Elizabeth Keoshkerian, Hui Li, Rachel Sacks-David, Irene Boo, Paul Dietze, Margaret Hellard, Heidi Drummer, Fabio Luciani, Rowena A Bull and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The ageing immune system and its battle with viruses.The Journal of general virology · 2026
    Review
  2. Functional Antigen-Specific CD8 TEuropean journal of immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanran ZhaoViral Immunology Systems Program (VISP), The Kirby Institute, University of New South Wales, Sydney, Australia.
Elizabeth KeoshkerianViral Immunology Systems Program (VISP), The Kirby Institute, University of New South Wales, Sydney, Australia.
Hui LiViral Immunology Systems Program (VISP), The Kirby Institute, University of New South Wales, Sydney, Australia.
Rachel Sacks-DavidBurnet Institute, Melbourne, VIC, Australia.
Irene BooBurnet Institute, Melbourne, VIC, Australia.
Paul DietzeBurnet Institute, Melbourne, VIC, Australia.
Margaret HellardBurnet Institute, Melbourne, VIC, Australia.
Heidi DrummerBurnet Institute, Melbourne, VIC, Australia.
Fabio LucianiSchool of Biomedical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.
Rowena A BullViral Immunology Systems Program (VISP), The Kirby Institute, University of New South Wales, Sydney, Australia.
Andrew R LloydViral Immunology Systems Program (VISP), The Kirby Institute, University of New South Wales, Sydney, Australia.

Funding

Australian National Health and Medical Research Council (NHMRC) APP1001144Australian National Health and Medical Research Council (NHMRC) APP1126090Australian National Health and Medical Research Council (NHMRC) APP1150078Australian National Health and Medical Research Council (NHMRC) APP2023690Australian National Health and Medical Research Council (NHMRC) APP545891NHMRC Career Development Fellowships APP1084706NHMRC Practitioner Fellowship APP1137587
6 · The paper itself

Abstract

Natural clearance of hepatitis C virus (HCV) infection occurs in about 25% of primary infections, but offers only partial protective immunity against re-infections. This study hypothesised that long-lived polyfunctional HCV-specific CD8+ memory stem T cells (T

Indexed as

CD8-Positive T-LymphocytesHepacivirusHepatitis CHepatitis C, ChronicImmunologic MemoryMemory T CellsAdultFemaleHumansLymphocyte ActivationMaleMiddle AgedCD8 T cellHCV re‐infectionlong‐lived protective immunitymemory T cell responsestem cell

Identifiers

PMID41410180
PMCPMC12712888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.